ASCRS $1 million better off

Article

Advanced Medical Optics (AMO) has pledged $1 million to support the American Society of Cataract and Refractive Surgery's (ASCRS) foundation sponsored research in the field of refractive lenticular science.

Advanced Medical Optics (AMO) has pledged $1 million to support the American Society of Cataract and Refractive Surgery's (ASCRS) foundation sponsored research in the field of refractive lenticular science.

The ASCRS Foundation funds ophthalmic research, public education and charitable activities in the developing world and in 2006 it is due to begin work on a multi-year programme supporting new research and educational programmes exploring the science of refractive lenticular surgery.

Re-brand for Ellex Medical Lasers

Ellex is to replace the brand "Laserex" and the company's US and Japanese subsidiaries will also adopt the name. The company is also due to relocate its global headquarters responsible for sales, marketing and customer services to San Francisco, US, in a move, that it says, will bring it closer to its three main markets of North America, North Asia and Europe. Ellex's manufacturing, engineering and finance operations will remain in Adelaide, Australia.

Ellex designs and manufactures various laser systems for the ophthalmic industry including photodisrupters, photocoagulators and selective laser trabeculoplasty systems.

Carl Zeiss Meditec to grow: not yet

At the company's fourth Annual General Meeting, more than 99% of the shareholders supported the initiative. Despite this broad approval, a small number lodged objections against the acquisition and all other items on the agenda. As a result, eight shareholders have now filed legal actions against the planned acquisition, which appears to have delayed the approval procedure. Nonetheless, Carl Zeiss Meditec's intention to acquire Carl Zeiss Surgical remains unchanged.

The acquisition is likely to make Carl Zeiss Meditec the third largest listed medical technology company in Germany.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.